Maneschi F, Benedetti-Panici P, Scambia G, Salerno M G, D'Agostino G, Mancuso S
Department of Gynecology and Obstetrics, Universitá Cattolica del Sacro Cuore, Rome, Italy.
Gynecol Oncol. 1994 Sep;54(3):345-8. doi: 10.1006/gyno.1994.1221.
Menstrual and hormone patterns were investigated in 10 fertile women (median age 37, range 25-43 years) with locally advanced cervical cancer treated with neoadjuvant chemotherapy (CT). CT consisted of two cycles of high-dose cisplatin (CDDP, 40 mg/m2, Days 1 to 4) and bleomycin (B, 15 mg/m2, Days 1 and 8) separated by an interval of 21 days. Menstrual patterns before and during CT were recorded. FSH, LH, estradiol, and progesterone were assayed on the day that treatment was begun, after 2 and 4 days of CDDP administration, and weekly between and after the two cycles. Hormone assays during the first week of CT showed no significant change in hormone levels. After the first course of CT, five patients showed hypergonadotrophic amenorrhea and five patients maintained menses, two showing ovulatory and three showing follicular phase hormone patterns. After the second course of CT, one more patient become amenorrheic, and endocrine follow-up showed that two patients maintained hypergonadotrophic amenorrhea, four with hypergonadotrophic amenorrhea had a return of hormone levels to the follicular range of 7-9 weeks after, three maintained follicular phase hormone patterns until operation, and one ovulated. Gonadal dysfunction should be included among the side effects of high-dose CDDP and B regimens.
对10名接受新辅助化疗(CT)的局部晚期宫颈癌的可育女性(中位年龄37岁,范围25 - 43岁)的月经和激素模式进行了研究。CT包括两个周期的高剂量顺铂(CDDP,40 mg/m²,第1至4天)和博来霉素(B,15 mg/m²,第1和8天),间隔21天。记录了CT前和CT期间的月经模式。在开始治疗当天、CDDP给药2天和4天后以及两个周期之间和之后每周测定促卵泡生成素(FSH)、促黄体生成素(LH)、雌二醇和孕酮。CT第一周期间的激素测定显示激素水平无显著变化。第一个CT疗程后,5名患者出现高促性腺激素性闭经,5名患者维持月经,2名显示排卵型,3名显示卵泡期激素模式。第二个CT疗程后,又有1名患者闭经,内分泌随访显示2名患者维持高促性腺激素性闭经,4名高促性腺激素性闭经患者在7 - 9周后激素水平恢复到卵泡期范围,3名患者在手术前维持卵泡期激素模式,1名患者排卵。性腺功能障碍应被纳入高剂量CDDP和B方案的副作用之中。